| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 16.192 | 20.588 | 23.699 | 33.178 | 39.541 | 35.641 | 39.841 |
| Total Income - EUR | - | - | - | 16.193 | 20.613 | 23.699 | 33.188 | 39.541 | 35.642 | 39.841 |
| Total Expenses - EUR | - | - | - | 8.805 | 16.664 | 20.452 | 18.961 | 20.064 | 23.108 | 18.335 |
| Gross Profit/Loss - EUR | - | - | - | 7.388 | 3.949 | 3.247 | 14.228 | 19.477 | 12.534 | 21.507 |
| Net Profit/Loss - EUR | - | - | - | 7.224 | 3.622 | 2.586 | 13.252 | 18.497 | 12.230 | 20.371 |
| Employees | - | - | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Prestjoint Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 802 | 38.871 | 27.587 | 16.754 | 6.736 | 859 | 0 |
| Current Assets | - | - | - | 6.767 | 1.629 | 4.037 | 10.754 | 25.464 | 32.902 | 54.691 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 32 | 53 | 2.285 | 5.199 | 23.821 | 30.615 | 51.382 |
| Cash | - | - | - | 6.735 | 1.576 | 1.752 | 5.555 | 1.643 | 2.287 | 3.309 |
| Shareholders Funds | - | - | - | 2.415 | 2.369 | 2.324 | 15.524 | 20.776 | 20.713 | 2.260 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 5.153 | 38.131 | 29.301 | 11.983 | 11.424 | 13.048 | 52.431 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Prestjoint Med S.r.l.